CD47, also called integrin-associated protein, is a transmembrane immune checkpoint protein on the surface of solid and hematologic cancer cells, whose overexpression is related to poor clinical prognoses [73]. Here, CD47 is linked to hematopoietic and lymphoid cell neoplasm.